Document Detail


Fibrinolytic treatment of postoperative deep venous thrombosis.
MedLine Citation:
PMID:  1166385     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Eleven patients with deep venous thrombosis were treated with streptokinase. Lysis of thrombi and prevention of pulmonay embolism were achieved in eight patients. Bleeding from the operative wound necessitated transfusions in seven patients. Fibrinolytic treatment of deep venous thrombosis lyses the floating portion of the thrombi. Protection against pulmonary embolism may be expected. The fibrinolytic effect of streptokinase is rapid; its value can be answered only by follow-up examinations.
Authors:
K E Giercksky; D G Sorlie; H Odegaard; J A Johnson
Related Documents :
24358135 - The effect of static stretch on elastin degradation in arteries.
897975 - Scintiscanning in venous thrombosis of the lower extremities.
1931535 - Patients' preferences for the site of injection of low-dose subcutaneous heparin in pro...
12575885 - Dvt prophylaxis and anticoagulation in the surgical patient.
9591535 - Late development of renal arteriovenous fistula following gunshot trauma--a case report.
10475445 - Vascular clamp for hemostasis and stabilization during minimally invasive direct corona...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Surgery, gynecology & obstetrics     Volume:  141     ISSN:  0039-6087     ISO Abbreviation:  Surg Gynecol Obstet     Publication Date:  1975 Oct 
Date Detail:
Created Date:  1975-12-12     Completed Date:  1975-12-12     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0101370     Medline TA:  Surg Gynecol Obstet     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  576-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Female
Hemorrhage / chemically induced
Heparin / administration & dosage,  therapeutic use
Humans
Infant
Infusions, Parenteral
Male
Middle Aged
Phlebography
Postoperative Complications
Streptokinase / administration & dosage,  adverse effects,  therapeutic use*
Thrombophlebitis / drug therapy*,  etiology
Warfarin / therapeutic use
Chemical
Reg. No./Substance:
81-81-2/Warfarin; 9005-49-6/Heparin; EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of the effect of fundoplication on the incompetent lower esophageal sphincter.
Next Document:  A new probe for measurement of muscle pO2 and its use during cardiopulmonary bypass.